Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59c6a921f33fe0adc58c2b6177184515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46c7a9e570defc3433a424dd2a0256c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2d0ffe490991acbef7eab06fec80080 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_978bbb93a7cffbb45b3b13ab597c4bc8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98f8d6bb55f5f15f4a93d00798fcbf7a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1830a34b0b44846fe65cea0ba2fd7718 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate |
2015-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0695bf2fa0c8cf20a6ab98dc8d884942 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeefabf9fa93c8fd256c3e5300ba4587 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60ec424919aae21f4ebeebb7275b11ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_276ca0787e9205098ad572791e14dab1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0718e0ef59490d5c96b6494440cb61d8 |
publicationDate |
2016-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2016030388-A1 |
titleOfInvention |
Diterpenoid membranolide compounds having anti-leishmania activity and uses thereof |
abstract |
In a screening program, the Antarctic sponge Dendrilla membranosa was found to produce diterpenoid secondary metabolites with activity against the leishmaniasis-causing parasite Leishmania donovani . The present invention concerns compositions useful for control of Leishmania spp. parasites in vitro and in vivo and treatment of leishmaniasis; methods for treatment of leishmaniasis; and methods for controlling Leishmania spp. parasites in vitro and in vivo. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019173382-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017177142-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11066379-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11213507-B2 |
priorityDate |
2014-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |